With the Indian government launching the ‘Pharma Vision 2047’, the focus is on making India a top global supplier of innovative and affordable medicines.
But here’s the gap: while the industry is moving towards biosimilars, digital manufacturing, and AI-based drug discovery — most B.Pharm students are still stuck learning outdated syllabus and manual tablet calculations.
If the future of pharma is high-tech and global, shouldn’t our classrooms evolve too? How do we bridge this gap before it’s too late?
It’s great to see India aiming to become a global pharma powerhouse. But strong industries need skilled professionals too. We, as students, need better hands-on training in regulatory affairs, manufacturing, and research. Things like live projects, industry partnerships, and updated labs would make a huge difference. With the right support, we can be ready let’s build that bridge.
Absolutely true, the Indian government has launched “Pharma Vision 2047”. But for this vision, the pharma syllabus should be updated and the students should learn software skills for better job opportunities.
I completely agree with this. The pharma industry is moving very fast with biosimilars, AI, and automation, but our classrooms are still teaching mostly old methods. Because of this, many pharmacy graduates come out with strong theory knowledge but very little idea about how the industry is actually working today. If we really want Pharma Vision 2047 to succeed, our education system should also change. Things like hands-on internships, exposure to modern lab equipment, training in digital tools, and updated syllabus are needed. This will help students not just pass exams but also become industry-ready.
Otherwise, there will always be a big gap between what companies need and what freshers know.
Absolutely, our education system needs to be technically updated as nearly all fields of pharmaceutical, from drug design to entering data of each medication have become digitalized. At least, the future students needs to be technically skilled along with theoretical knowledge to secure better career opportunities in this modern world.
That’s such an important point. The pharma industry is moving forward, but if students aren’t trained in modern tools and technologies, the gap will only widen. Updating the curriculum and giving hands-on exposure is the need of the hour.
I don’t think India is ready for this level of responsibility yet, which is evident from recent incidents where quality and efficacy inconsistencies were found in our commercial chemotherapy drugs.
Our half-hearted focus towards the improvement of pharmaceutical operations and education will being a lot of legal casualties if we take up the challenge now. It is too soon for us, something has to change first.
If the future of pharma is high-tech and global, shouldn’t our classrooms evolve too? How do we bridge this gap before it’s too late?